Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

apnexmedical.com

Founded Year

2006

Stage

Dead | Dead

Total Raised

$60.1M

About Apnex Medical

Apnex Medical is focused on helping to improve the health of people with sleep disordered breathing. Apnex is developing an active implantable medical device for the treatment of obstructive sleep apnea (OSA). This disorder is associated with significant long-term health problems.

Apnex Medical Headquarters Location

2890 Centre Pointe Drive Suite 413

Saint Paul, Minnesota, 55113,

United States

651-757-4300

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Apnex Medical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Apnex Medical is included in 1 Expert Collection, including Sleep Health & Wellness.

S

Sleep Health & Wellness

801 items

These companies aim to assess or improve the quantity/quality of sleep, or use sleep data in the monitoring or diagnosis of other health conditions.

Apnex Medical Patents

Apnex Medical has filed 7 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/29/2010

7/30/2013

Sleep disorders, Sleep physiology, Abnormal respiration, Sleep, Breathing abnormalities

Grant

Application Date

12/29/2010

Grant Date

7/30/2013

Title

Related Topics

Sleep disorders, Sleep physiology, Abnormal respiration, Sleep, Breathing abnormalities

Status

Grant

Latest Apnex Medical News

Sleep apnea device maker lands $10M

Sep 25, 2012

Apnex Medical, maker of respiratory devices for patients with sleep disordered breathing, touts a $10 million infusion from New Enterprise Associates. Apnex Medical touted a $10 million funding infusion from New Enterprise Associates, planning on using the money to support its ongoing clinical studies. The St. Paul, Minn.-based respiratory devices company is amid clinical studies for its Hypoglossal Nerve Stimulation System for use in patients with obstructive sleep apnea. News Well, Funding Roundup, Respiratory, Sleep Monitoring/Sleep Apnearead more

  • When was Apnex Medical founded?

    Apnex Medical was founded in 2006.

  • Where is Apnex Medical's headquarters?

    Apnex Medical's headquarters is located at 2890 Centre Pointe Drive, Saint Paul.

  • What is Apnex Medical's latest funding round?

    Apnex Medical's latest funding round is Dead.

  • How much did Apnex Medical raise?

    Apnex Medical raised a total of $60.1M.

  • Who are the investors of Apnex Medical?

    Investors of Apnex Medical include New Enterprise Associates, Domain Associates, Polaris Partners and Michael Berman.

  • Who are Apnex Medical's competitors?

    Competitors of Apnex Medical include Itamar Medical, Respicardia, Endologix, Myomo, SonarMed and 14 more.

You May Also Like

C
CoRepair

CoRepair, Inc. is developing a radiofrequency (RF) device system for the treatment of congestive heart failure.

C
Chase Medical

Chase Medical is developing medical technology for treating congestive heart failure. Chase Medical is developing a device called the Mannequin which aims to help the heart maintain its shape while going through reconstruction of the left ventricle.

O
Otologics

Otologics is a medical device company developing implantable hearing systems and accessories designed to enhance communication and improve the quality of life for individuals with hearing loss.

C
Cardiac Power

Cardiac Power is a non-blood-contacting left ventricular assist device for the treatment of congestive heart failure

V
Viacor

Viacor is a development stage company dedicated to pioneering catheter-based techniques for the treatment of congestive heart failure.

H
Hemosphere (formerly GRAFTcath)

Hemosphere (formerly GRAFTcath) has developed a vascular access product that has the potential to reduce the risk of bacteremia, or severe infection, posed to catheter-dependent patients undergoing hemodialysis.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.